Eurofins-Cerep SA (ALECR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Eurofins-Cerep SA (ALECR) has a cash flow conversion efficiency ratio of -0.043x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-3.19 Million ≈ $-3.73 Million USD) by net assets (€73.54 Million ≈ $85.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Eurofins-Cerep SA (ALECR) market capitalisation for the company's overall valuation and market capitalisation.
Eurofins-Cerep SA - Cash Flow Conversion Efficiency Trend (2001–2017)
This chart illustrates how Eurofins-Cerep SA's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Eurofins-Cerep SA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Eurofins-Cerep SA ranked by their cash flow conversion efficiency. Explore Eurofins-Cerep SA cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Demco Public Company Limited
BK:DEMCO
|
-0.004x |
|
GrandTech C.G. Systems
TWO:6123
|
0.118x |
|
IX Acquisition Corp
NASDAQ:IXAQ
|
-0.043x |
|
Vizsla Copper Corp
V:VCU
|
-0.037x |
|
Shinyoung Waco
KO:005800
|
0.040x |
|
Vow ASA
OL:VOW
|
0.300x |
|
Empery Digital Inc.
NASDAQ:EMPD
|
-0.021x |
|
ASUNTOSALKKU A EO 1
F:H57
|
N/A |
Annual Cash Flow Conversion Efficiency for Eurofins-Cerep SA (2001–2017)
The table below shows the annual cash flow conversion efficiency of Eurofins-Cerep SA from 2001 to 2017. View Eurofins-Cerep SA share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2017-12-31 | €21.31 Million ≈ $24.91 Million |
€4.24 Million ≈ $4.95 Million |
0.199x | -37.92% |
| 2016-12-31 | €17.46 Million ≈ $20.41 Million |
€5.59 Million ≈ $6.54 Million |
0.320x | +1002.79% |
| 2015-12-31 | €14.97 Million ≈ $17.50 Million |
€434.88K ≈ $508.42K |
0.029x | +116.50% |
| 2014-12-31 | €13.16 Million ≈ $15.39 Million |
€-2.32 Million ≈ $-2.71 Million |
-0.176x | -328.97% |
| 2013-12-31 | €13.35 Million ≈ $15.60 Million |
€1.03 Million ≈ $1.20 Million |
0.077x | -5.29% |
| 2012-12-31 | €13.93 Million ≈ $16.29 Million |
€1.13 Million ≈ $1.32 Million |
0.081x | -68.70% |
| 2011-12-31 | €13.57 Million ≈ $15.86 Million |
€3.52 Million ≈ $4.11 Million |
0.259x | +421.40% |
| 2010-12-31 | €13.63 Million ≈ $15.94 Million |
€-1.10 Million ≈ $-1.29 Million |
-0.081x | -228.71% |
| 2009-12-31 | €18.90 Million ≈ $22.10 Million |
€1.19 Million ≈ $1.39 Million |
0.063x | -72.44% |
| 2008-12-31 | €21.47 Million ≈ $25.10 Million |
€4.88 Million ≈ $5.71 Million |
0.227x | +29.62% |
| 2007-12-31 | €23.92 Million ≈ $27.96 Million |
€4.20 Million ≈ $4.91 Million |
0.175x | +199.55% |
| 2006-12-31 | €14.12 Million ≈ $16.51 Million |
€-2.49 Million ≈ $-2.91 Million |
-0.176x | -391.06% |
| 2005-12-31 | €31.13 Million ≈ $36.40 Million |
€1.89 Million ≈ $2.20 Million |
0.061x | -79.31% |
| 2004-12-31 | €32.05 Million ≈ $37.47 Million |
€9.38 Million ≈ $10.97 Million |
0.293x | +139.87% |
| 2003-12-31 | €29.66 Million ≈ $34.68 Million |
€3.62 Million ≈ $4.23 Million |
0.122x | -16.88% |
| 2002-12-31 | €29.32 Million ≈ $34.28 Million |
€4.30 Million ≈ $5.03 Million |
0.147x | +159.56% |
| 2001-12-31 | €26.17 Million ≈ $30.60 Million |
€1.48 Million ≈ $1.73 Million |
0.057x | -- |
About Eurofins-Cerep SA
Eurofins-Cerep SA provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally. The company also provides research services, including compound management, and high-throughout screening and profiling. The company was formerly known as Cerep SA and changed its name to Eurofins-Cerep SA in June 2014. Eurofins-Cerep SA was foun… Read more